Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FMAQL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,807
Award facts
- Contract value 100% obligated
- $48,806.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Dupixent 300 mg/2 ml pen auto-injectors valued at $48,806.56. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded delivery orders and standing contracts. Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis and other inflammatory conditions, making this procurement aligned with the Defense Health Agency's medical supply requirements for military personnel and veterans. The award demonstrates AmerisourceBergen's continued role as a primary pharmaceutical vendor within the DLA's medical supply chain, fulfilling specialized pharmaceutical needs on a delivery order basis under its established indefinite delivery contract vehicle.
Quick answers
Who was awarded contract SPE2DB26FMAQL?
SPE2DB26FMAQL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FMAQL worth?
The government has obligated $48,807 on SPE2DB26FMAQL.
Is contract SPE2DB26FMAQL an order under another contract?
Yes. SPE2DB26FMAQL is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMAQL competed?
The extent of competition for SPE2DB26FMAQL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award